U.S., April 29 -- ClinicalTrials.gov registry received information related to the study (NCT07553663) titled 'Evaluating the Pharmacokinetics and Safety of Miricorilant' on April 14.
Brief Summary: A Phase 1b, Open-Label Study Evaluating the Pharmacokinetics and Safety of Miricorilant in Adult Patients With Presumed Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Study Start Date: April 30
Study Type: INTERVENTIONAL
Condition:
Nonalcoholic Steatohepatitis (NASH)
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
Non-alcoholic Fatty Liver Disease (NAFLD)
Intervention:
DRUG: Miricorilant
Single...